BioMarin Pharmaceutical Inc.
DE ˙ DB ˙ US09061G1013
46,59 € ↑0,90 (1,97%)
2026-06-04
AKTIENPREIS
SecurityDE:BM8 / BioMarin Pharmaceutical Inc.
InstitutionCerity Partners LLC
Latest Disclosed Ownership263,389 shares
Latest Disclosed Value $ 14,878,828
Cerity Partners LLC reports 0.10% increase in ownership of BM8 / BioMarin Pharmaceutical Inc.

On May 15, 2026 - Cerity Partners LLC filed a 13F-HR form disclosing ownership of 263,389 shares of BioMarin Pharmaceutical Inc. (DE:BM8) valued at $12,637,404 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 11, 2026 disclosing 263,128 shares of BioMarin Pharmaceutical Inc.. This represents a change in shares of 0.10% during the quarter. The current value of the position is $12,271,294 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-05-15 2026-03-31 13F BIOMARIN PHARMACEUTICAL COM 09061G101 263,389 261 0.10 14,879 -4.85 0.0104
2026-02-11 2025-12-31 13F BIOMARIN PHARMACEUTICAL COM 09061G101 263,128 70,861 36.86 15,638 50.17 0.0228
2025-10-22 2025-09-30 13F BIOMARIN PHARMACEUTICAL Stock 09061G101 192,267 26,836 16.22 10,413 14.52 0.0169
2025-08-13 2025-06-30 13F BIOMARIN PHARMACEUTICAL Stock 09061G101 165,431 80,599 95.01 9,094 51.65 0.0162
2025-04-30 2025-03-31 13F BIOMARIN PHARMACEUTICAL Stock 09061G101 84,832 56,897 203.68 5,997 222.71 0.0121
2025-02-13 2024-12-31 13F BIOMARIN PHARMACEUTICAL COM 09061G101 27,935 -3,376 -10.78 1,858 -15.55 0.0040
2024-11-12 2024-09-30 13F BIOMARIN PHARMACEUTICAL Stock 09061G101 31,311 23,683 310.47 2,201 250.88 0.0049
2024-08-13 2024-06-30 13F BIOMARIN PHARMACEUTICAL Stock 09061G101 7,628 634 9.06 628 2.79 0.0017
2024-05-14 2024-03-31 13F BIOMARIN PHARMACEUTICAL Stock 09061G101 6,994 3,891 125.39 611 104.01 0.0016
2024-01-26 2023-12-31 13F BIOMARIN PHARMACEUTICAL COM 09061G101 3,103 3,103 299 0.0010
2023-11-14 2023-09-30 13F BIOMARIN PHARMACEUTICAL COM 09061G101 0 -3,935 -100.00 0 -100.00
2023-08-14 2023-06-30 13F BIOMARIN PHARMACEUTICAL COM 09061G101 3,935 215 5.78 341 -5.54 0.0013
2023-05-11 2023-03-31 13F BIOMARIN PHARMACEUTICAL Stock 09061G101 3,720 389 11.68 362 4.94 0.0009
2023-02-15 2022-12-31 13F BIOMARIN PHARMACEUTICAL Stock 09061G101 3,331 480 16.84 345 42.15 0.0022
2022-11-14 2022-09-30 13F BIOMARIN PHARMACEUTICAL Stock 09061G101 2,851 -445 -13.50 242 -11.36 0.0029
2022-08-10 2022-06-30 13F BIOMARIN PHARMACEUTICAL STOCK 09061G101 3,296 3,296 273 0.0030
2022-04-25 2022-03-31 13F BIOMARIN PHARMACEUTICAL Stock 09061G101 0 -2,301 -100.00 0 -100.00
2022-02-14 2021-12-31 13F BIOMARIN PHARMACEUTICAL Stock 09061G101 2,301 2,301 205 0.0031
2019-10-30 2019-09-30 13F BIOMARIN PHARMACEUTICAL COM 09061G101 0 -2,439 -100.00 0 -100.00
2019-08-14 2019-06-30 13F BIOMARIN PHARMACEUTICAL COM 09061G101 2,439 16 0.66 209 -2.79 0.0132
2019-05-14 2019-03-31 13F BIOMARIN PHARMACEUTICAL COM 09061G101 2,423 -158 -6.12 215 -2.27 0.0145
2019-02-06 2018-12-31 13F BIOMARIN PHARMACEUTICAL COM 09061G101 2,581 103 4.16 220 -8.33 0.0147
2018-11-15 2018-09-30 13F BIOMARIN PHARMACEUTICAL COM 09061G101 2,478 -38 -1.51 240 1.27 0.0166
2018-08-15 2018-06-30 13F BIOMARIN PHARMACEUTICAL COM 09061G101 2,516 -2,035 -44.72 237 -35.77 0.0175
2018-05-15 2018-03-31 13F BIOMARIN PHARMACEUTICAL COM 09061G101 4,551 -79 -1.71 369 -10.65 0.0282
2018-02-14 2017-12-31 13F BioMarin Pharmaceutical COM 09061G101 4,630 -235 -4.83 413 -8.83 0.0277
2017-11-13 2017-09-30 13F BIOMARIN PHARMACEUTICAL COM 09061G101 4,865 -95 -1.92 453 0.67 0.0321
2017-08-10 2017-06-30 13F BioMarin Pharmaceutical COM 09061G101 4,960 -2,418 -32.77 450 -30.56 0.0377
2017-05-02 2017-03-31 13F BioMarin Pharmaceutical COM 09061G101 7,378 7,378 648 0.0541
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.